Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Curr Biol. 2010 Jun 22;20(12):1093-8. doi: 10.1016/j.cub.2010.04.041. Epub 2010 May 27.
Autophagy, a catabolic process responsible for the degradation of cytosolic components, is upregulated when nutrient supplies are limited. A critical step in autophagy induction comprises the inactivation of a key negative regulator of the process, the Ser/Thr kinase mammalian target of rapamycin (mTOR). Thus far, only a few substrates of mTOR that control autophagy have been identified, including ULK1 and Atg13, both of which function as positive mediators. Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy. The link of DAP1 to autophagy was first apparent in that its knockdown enhanced autophagic flux and in that it displayed a rapid decline in its phosphorylation in response to amino acid starvation. Mapping of the phosphorylation sites and analysis of phosphorylation mutants indicated that DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51. Inactivation of mTOR during starvation caused a rapid reduction in these phosphorylation sites and converted the protein into an active suppressor of autophagy. These results are consistent with a "Gas and Brake" model in which mTOR inhibition also controls a buffering mechanism that counterbalances the autophagic flux and prevents its overactivation under nutrient deprivation.
自噬是一种负责降解细胞质成分的分解代谢过程,当营养供应有限时,自噬会被上调。自噬诱导的一个关键步骤包括使过程的关键负调控因子丝氨酸/苏氨酸激酶哺乳动物雷帕霉素靶蛋白(mTOR)失活。到目前为止,已经鉴定出了少数控制自噬的 mTOR 底物,包括 ULK1 和 Atg13,它们都作为正向调节剂发挥作用。在这里,我们发现死亡相关蛋白 1(DAP1)是一种新的 mTOR 底物,它负调控自噬。DAP1 与自噬的联系首先是明显的,因为它的敲低增强了自噬流,并且它在响应氨基酸饥饿时迅速降低其磷酸化。磷酸化位点的映射和磷酸化突变体的分析表明,DAP1 通过 mTOR 依赖性 Ser3 和 Ser51 磷酸化在生长细胞中被功能沉默。在饥饿期间 mTOR 的失活导致这些磷酸化位点的快速减少,并将该蛋白转化为自噬的有效抑制剂。这些结果与“油门和刹车”模型一致,即 mTOR 抑制还控制着一种缓冲机制,该机制可以平衡自噬流,并防止其在营养缺乏下过度激活。
Curr Biol. 2010-5-27
Cell Signal. 2010-1-28
Mol Biol Cell. 2009-4
Biochem J. 2011-12-1
J Biol Chem. 2016-3-11
Liver Res. 2023-2-19
Biomolecules. 2024-11-15
Mar Drugs. 2024-3-8
J Orthop Surg Res. 2023-9-21
Int J Mol Med. 2023-10
Front Pharmacol. 2023-3-8